Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson's Disease Model by Alleviating Mitochondrial Dysfunction.

MLA

Aleksandrova, Yulia, et al. “Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction.” International Journal of Molecular Sciences, vol. 24, no. 6, Mar. 2023. EBSCOhost, https://doi.org/10.3390/ijms24065842.

APA

Aleksandrova, Y., Chaprov, K., Podturkina, A., Ardashov, O., Yandulova, E., Volcho, K., Salakhutdinov, N., & Neganova, M. (2023). Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction. International Journal of Molecular Sciences, 24(6). https://doi.org/10.3390/ijms24065842

Chicago

Aleksandrova, Yulia, Kirill Chaprov, Alexandra Podturkina, Oleg Ardashov, Ekaterina Yandulova, Konstantin Volcho, Nariman Salakhutdinov, and Margarita Neganova. 2023. “Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction.” International Journal of Molecular Sciences 24 (6). doi:10.3390/ijms24065842.